Ex parte ZINKE et al. - Page 6




          Appeal No. 1997-1875                                                        
          Application No. 08/451,378                                                  


          narrow in scope than the here claimed subject matter.  It is                
          well established that evidence presented to rebut a prima                   
          facie case of obviousness must be commensurate in scope with                
          the claims to which it pertains and that evidence which is                  
          considerably more narrow in scope than the claimed subject                  
          matter is not sufficient to rebut a prima facie case.  In re                
          Dill, 604 F.2d 1356, 1360, 202 USPQ 805, 808 (CCPA 1979).                   
          Thus, the appellants' evidence of nonobviousness is deficient               
          in that it does not show the class of compounds defined by                  
          their independent claim to be unexpectedly superior as a class              
          to the comparison prior art compounds.  In re Susi, 440 F.2d                
          442, 446, 169 USPQ 423, 426 (CCPA 1971).                                    
               The appellants argue "the examiner has not met the burden              
          of presenting objective evidence or sound scientific reasoning              
          to support the conclusion that all of the claimed compounds                 
          would not be expected to have a stabilizing effect similar to               
          the [inventive] compounds exemplified in the two Zinke                      
          Declarations" (Brief, page 7).  It is, however, the                         
          appellants' burden to show that their claimed compounds as a                
          class possess the superiority asserted in the declarations.                 
          In re Susi, id.  Regardless, there is in fact evidence and                  
                                          6                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007